Current pharmaceutical biotechnology2026,Vol.27Issue(5) :593-605,ⅲ.DOI:10.2174/0113892010337908241129055322

Biomimetic Fe_3O_4 Nanozymes Promote Apoptosis in Breast Cancer Cell Lines via Free Radical Scavenging and Inhibition of RelA/p65

Deepa Mundekkad William C.S. Cho
Current pharmaceutical biotechnology2026,Vol.27Issue(5) :593-605,ⅲ.DOI:10.2174/0113892010337908241129055322

Biomimetic Fe_3O_4 Nanozymes Promote Apoptosis in Breast Cancer Cell Lines via Free Radical Scavenging and Inhibition of RelA/p65

Deepa Mundekkad 1William C.S. Cho2
扫码查看

作者信息

  • 1. Department of Biotechnology, Nehru Arts and Science College, Thirumalayampalayam, Coimbatore, Tamilnadu, 641105, India
  • 2. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
  • 折叠

Abstract

Introduction: Iron oxide nanozyme was synthesized from the fruit peel extract of pomegranate, which served as a reducing agent during the green synthesis. The scavenging of reactive oxygen species is often accompanied by immunomodulation following antiproliferative effects due to the crosstalk between the proteins involved in the inter-related signaling pathways. Methods: In the current study, the green synthesized nanozyme was studied for its ability to induce apoptosis in breast cancer cell lines. The free radical scavenging effect of the nanozyme was reflected as an extension of its intrinsic endogenous enzyme-mimicking property. Results & Discussion: The cell cycle analysis revealed that the cell death induced by nanozyme mainly affected the G0/G1 phase. The expression of RelA/p65 and the inflammatory mediators affected by the nanozyme established the role of the Fe_3O_4 nanozyme in immunomodulation along with its antiproliferative activity. Conclusion: This is the first report on the antiproliferative and immunomodulatory activities expressed by the biomimetic iron oxide nanozyme.

Key words

Biomimetic/green synthesis/iron oxide nanozyme/ROS-scavenging/cell cycle analysis/apoptosis/RelA/p65/COX-2/nitric oxide/immunomodulation

引用本文复制引用

出版年

2026
Current pharmaceutical biotechnology

Current pharmaceutical biotechnology

ISSN:1389-2010
段落导航相关论文